Top Clinical Trials companies in Taiwan by EBITDA

This ranking features the top 3 Clinical Trials companies in Taiwan ranked by EBITDA, totalling a EBITDA of USD -65.32 M, for January 15, 2025.
#
Name
EBITDA
Reported Date
Stock Price
Change
Price (30 days) Country
1
USD -821.94 K
Dec. 31, 2023 USD 2.64 -2.78%

Taiwan

2
USD -27.85 M
Dec. 31, 2023 USD 1.70 1.57%

Taiwan

3
USD -36.65 M
Dec. 31, 2023 USD 0.93 4.52%

Taiwan

Frequently Asked Questions
  • Which Clinical Trials company in Taiwan has the highest EBITDA ?

    The Clinical Trials company in Taiwan with the highest EBITDA is TaiMed Biologics Inc. (Taipei Exchange: 4147.TWO) at USD -821.94 K.

  • Which Clinical Trials company in Taiwan has the lowest EBITDA ?

    The Clinical Trials company in Taiwan with the lowest EBITDA is Microbio Co., Ltd. (Taipei Exchange: 4128.TWO) at USD -36.65 M.